Seikagaku Corporation (TYO:4548)

Market Cap	34.66B
Revenue (ttm)	38.08B
Net Income (ttm)	-887.00M
Shares Out	54.58M
EPS (ttm)	-16.25
PE Ratio	n/a
Forward PE	n/a
Dividend	30.00 (4.72%)
Ex-Dividend Date	Sep 29, 2025

Volume	283,700
Average Volume	220,990
Open	640.00
Previous Close	640.00
Day's Range	632.00 - 640.00
52-Week Range	603.00 - 883.00
Beta	0.25
RSI	44.97
Earnings Date	Aug 5, 2025

About Seikagaku

Seikagaku Corporation manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally.The company operates in two segments, Pharmaceuticals and LAL Business. It offers pharmaceuticals and medical devices, including intra-articular injections for improving joint functions under the brands of ARTZ, ARTZ Dispo, VISCO-3, JOYCLU Gel-One, Hylink, and SUPARTZ FX; ophthalmic surgical aids under the OPEGAN and SHELLGAN brands; surgical aids for endoscopic mucosal resection under the brand name...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1947
• Employees: 1,075
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4548

Financial Performance

In 2024, Seikagaku's revenue was 39.37 billion, an increase of 8.73% compared to the previous year's 36.21 billion. Earnings were 1.21 billion, a decrease of -44.46%.